160 related articles for article (PubMed ID: 37870275)
1. PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification.
Kang H; Park S; Jo A; Mao X; Kumar M; Park CH; Ahn JY; Lee Y; Choi JY; Lee YS; Dawson VL; Dawson TM; Kam TI; Shin JH
EMBO Rep; 2023 Nov; 24(11):e56166. PubMed ID: 37870275
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease.
Kam TI; Mao X; Park H; Chou SC; Karuppagounder SS; Umanah GE; Yun SP; Brahmachari S; Panicker N; Chen R; Andrabi SA; Qi C; Poirier GG; Pletnikova O; Troncoso JC; Bekris LM; Leverenz JB; Pantelyat A; Ko HS; Rosenthal LS; Dawson TM; Dawson VL
Science; 2018 Nov; 362(6414):. PubMed ID: 30385548
[TBL] [Abstract][Full Text] [Related]
3. S-nitrosylated PARIS Leads to the Sequestration of PGC-1α into Insoluble Deposits in Parkinson's Disease Model.
Kim H; Lee JY; Park SJ; Kwag E; Kim J; Shin JH
Cells; 2022 Nov; 11(22):. PubMed ID: 36429110
[TBL] [Abstract][Full Text] [Related]
4. PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.
Lee Y; Stevens DA; Kang SU; Jiang H; Lee YI; Ko HS; Scarffe LA; Umanah GE; Kang H; Ham S; Kam TI; Allen K; Brahmachari S; Kim JW; Neifert S; Yun SP; Fiesel FC; Springer W; Dawson VL; Shin JH; Dawson TM
Cell Rep; 2017 Jan; 18(4):918-932. PubMed ID: 28122242
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
Feng X; Koh DW
Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
[TBL] [Abstract][Full Text] [Related]
6. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.
Shin JH; Ko HS; Kang H; Lee Y; Lee YI; Pletinkova O; Troconso JC; Dawson VL; Dawson TM
Cell; 2011 Mar; 144(5):689-702. PubMed ID: 21376232
[TBL] [Abstract][Full Text] [Related]
7. Poly (ADP-ribose) in the pathogenesis of Parkinson's disease.
Lee Y; Kang HC; Lee BD; Lee YI; Kim YP; Shin JH
BMB Rep; 2014 Aug; 47(8):424-32. PubMed ID: 24874851
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death.
Ying W; Sevigny MB; Chen Y; Swanson RA
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12227-32. PubMed ID: 11593040
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.
Khang R; Park C; Shin JH
Neuroscience; 2015 May; 294():182-92. PubMed ID: 25779963
[TBL] [Abstract][Full Text] [Related]
10. Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration.
Kim H; Shin JY; Jo A; Kim JH; Park S; Choi JY; Kang HC; Dawson VL; Dawson TM; Shin JH; Lee Y
Brain; 2021 Dec; 144(12):3674-3691. PubMed ID: 34581802
[TBL] [Abstract][Full Text] [Related]
11. Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage.
Kang HC; Lee YI; Shin JH; Andrabi SA; Chi Z; Gagné JP; Lee Y; Ko HS; Lee BD; Poirier GG; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14103-8. PubMed ID: 21825151
[TBL] [Abstract][Full Text] [Related]
12. p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.
Dutto I; Sukhanova M; Tillhon M; Cazzalini O; Stivala LA; Scovassi AI; Lavrik O; Prosperi E
PLoS One; 2016; 11(1):e0146031. PubMed ID: 26730949
[TBL] [Abstract][Full Text] [Related]
13. Repression of rRNA transcription by PARIS contributes to Parkinson's disease.
Kang H; Shin JH
Neurobiol Dis; 2015 Jan; 73():220-8. PubMed ID: 25315684
[TBL] [Abstract][Full Text] [Related]
14. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
[TBL] [Abstract][Full Text] [Related]
15. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
[TBL] [Abstract][Full Text] [Related]
16. Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.
Horton JK; Stefanick DF; Gassman NR; Williams JG; Gabel SA; Cuneo MJ; Prasad R; Kedar PS; Derose EF; Hou EW; London RE; Wilson SH
DNA Repair (Amst); 2013 Sep; 12(9):774-85. PubMed ID: 23871146
[TBL] [Abstract][Full Text] [Related]
17. PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease.
Jo A; Lee Y; Kam TI; Kang SU; Neifert S; Karuppagounder SS; Khang R; Kang H; Park H; Chou SC; Oh S; Jiang H; Swing DA; Ham S; Pirooznia S; Umanah GKE; Mao X; Kumar M; Ko HS; Kang HC; Lee BD; Lee YI; Andrabi SA; Park CH; Lee JY; Kim H; Kim H; Kim H; Cho JW; Paek SH; Na CH; Tessarollo L; Dawson VL; Dawson TM; Shin JH
Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321320
[TBL] [Abstract][Full Text] [Related]
18. PARP Inhibitors and Parkinson's Disease.
Olsen AL; Feany MB
N Engl J Med; 2019 Jan; 380(5):492-494. PubMed ID: 30699325
[No Abstract] [Full Text] [Related]
19. The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency.
Gatti M; Imhof R; Huang Q; Baudis M; Altmeyer M
Cell Rep; 2020 Aug; 32(5):107985. PubMed ID: 32755579
[TBL] [Abstract][Full Text] [Related]
20. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
